Prothena Corp Public Ltd Co

Ownership Transactions Reported by 23 Insiders

Symbol
PRTA on Nasdaq
Industry
Pharmaceutical Preparations
Location
77 Sir John Rogerson's Quay, Block C, Grand Canal Docklands, Dublin 2, Ireland

Insiders trading volume in the past year

Prothena Corp Public Ltd Co executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
EcoR1 Capital, LLC 10%+ Owner $336M May 5, 2022
Gene G. Kinney President and CEO $435K Feb 27, 2024
Dennis J. Selkoe Director $143K May 15, 2024
Tran Nguyen Chief Strategy Officer and CFO $109K Feb 27, 2024
Helen S. Kim Director May 15, 2024
Shane Cooke Director May 15, 2024
Sanjiv Patel Director May 18, 2022
Karl Anders Olof Harfstrand Director May 17, 2023
Wagner M. Zago Chief Scientific Officer Feb 27, 2024
Michael J. Malecek Chief Legal Officer Feb 27, 2024
Radhika Tripuraneni Chief Development Officer Feb 23, 2022
Hideki Garren Chief Medical Officer Feb 27, 2024
Richard T. Collier Director May 15, 2024
Christopher S. Henney Director Jul 14, 2021
Lars Ekman Director May 15, 2024
Paula K. Cobb Director May 15, 2024
Carol D. Karp Chief Regulatory Officer Feb 27, 2024
Brandon S. Smith Chief Operating Officer Feb 27, 2024
David A. Ford Chief People Officer Mar 1, 2024
William H. Dunn Jr. Director May 15, 2024
Daniel G. Welch Director May 15, 2024
Chad J. Swanson Chief Development Officer Oct 1, 2024
Karin L. Walker Chief Accounting Officer -$170K Feb 27, 2024

Recent Insider Transactions by Companies or Individuals for Prothena Corp Public Ltd Co

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.